289 related articles for article (PubMed ID: 25138089)
21. New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now?
Feng SS
Nanomedicine (Lond); 2006 Oct; 1(3):297-309. PubMed ID: 17716160
[TBL] [Abstract][Full Text] [Related]
22. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
23. Progresses in polymeric nanoparticles for delivery of tyrosine kinase inhibitors.
Foroughi-Nia B; Barar J; Memar MY; Aghanejad A; Davaran S
Life Sci; 2021 Aug; 278():119642. PubMed ID: 34033837
[TBL] [Abstract][Full Text] [Related]
24. Clinical developments in nanotechnology for cancer therapy.
Heidel JD; Davis ME
Pharm Res; 2011 Feb; 28(2):187-99. PubMed ID: 20549313
[TBL] [Abstract][Full Text] [Related]
25. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
Pridgen EM; Langer R; Farokhzad OC
Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
[TBL] [Abstract][Full Text] [Related]
26. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
27. pH-sensitive nano-systems for drug delivery in cancer therapy.
Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
[TBL] [Abstract][Full Text] [Related]
28. Smart Drug-Delivery Systems for Cancer Nanotherapy.
Sanchez-Moreno P; Ortega-Vinuesa JL; Peula-Garcia JM; Marchal JA; Boulaiz H
Curr Drug Targets; 2018 Feb; 19(4):339-359. PubMed ID: 27231107
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
[TBL] [Abstract][Full Text] [Related]
30. Stimuli-Responsive Programmed Specific Targeting in Nanomedicine.
Wang S; Huang P; Chen X
ACS Nano; 2016 Mar; 10(3):2991-4. PubMed ID: 26881288
[TBL] [Abstract][Full Text] [Related]
31. Nanomedicines for developing cancer nanotherapeutics: from benchtop to bedside and beyond.
Iqbal J; Abbasi BA; Ahmad R; Mahmood T; Ali B; Khalil AT; Kanwal S; Shah SA; Alam MM; Badshah H; Munir A
Appl Microbiol Biotechnol; 2018 Nov; 102(22):9449-9470. PubMed ID: 30219952
[TBL] [Abstract][Full Text] [Related]
32. Influence of nanomedicine mechanical properties on tumor targeting delivery.
Li Z; Xiao C; Yong T; Li Z; Gan L; Yang X
Chem Soc Rev; 2020 Apr; 49(8):2273-2290. PubMed ID: 32215407
[TBL] [Abstract][Full Text] [Related]
33. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
[TBL] [Abstract][Full Text] [Related]
34. Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.
Niu Y; Zhu J; Li Y; Shi H; Gong Y; Li R; Huo Q; Ma T; Liu Y
J Control Release; 2018 May; 277():35-47. PubMed ID: 29545106
[TBL] [Abstract][Full Text] [Related]
35. Medical and dental applications of nanomedicines.
Kavoosi F; Modaresi F; Sanaei M; Rezaei Z
APMIS; 2018 Oct; 126(10):795-803. PubMed ID: 30264432
[TBL] [Abstract][Full Text] [Related]
36. Stimuli-responsive polymeric nanoparticles for nanomedicine.
Crucho CI
ChemMedChem; 2015 Jan; 10(1):24-38. PubMed ID: 25319803
[TBL] [Abstract][Full Text] [Related]
37. Toward therapeutic delivery with layer-by-layer engineered particles.
Yan Y; Such GK; Johnston AP; Lomas H; Caruso F
ACS Nano; 2011 Jun; 5(6):4252-7. PubMed ID: 21612259
[TBL] [Abstract][Full Text] [Related]
38. Nanotechnology platforms; an innovative approach to brain tumor therapy.
Nair BG; Varghese SH; Nair R; Yoshida Y; Maekawa T; Kumar DS
Med Chem; 2011 Sep; 7(5):488-503. PubMed ID: 21801148
[TBL] [Abstract][Full Text] [Related]
39. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
40. Polymeric nanoparticulates for cancer immunotherapy.
Li W; Feng SS; Guo Y
Nanomedicine (Lond); 2013 May; 8(5):679-82. PubMed ID: 23656262
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]